These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 8794769
1. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Liu R, Sharom FJ. Biochemistry; 1996 Sep 10; 35(36):11865-73. PubMed ID: 8794769 [Abstract] [Full Text] [Related]
2. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter. Liu R, Sharom FJ. Biochemistry; 1997 Mar 11; 36(10):2836-43. PubMed ID: 9062112 [Abstract] [Full Text] [Related]
3. Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study. Liu R, Sharom FJ. Biochemistry; 1998 May 05; 37(18):6503-12. PubMed ID: 9572868 [Abstract] [Full Text] [Related]
4. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Romsicki Y, Sharom FJ. Biochemistry; 1999 May 25; 38(21):6887-96. PubMed ID: 10346910 [Abstract] [Full Text] [Related]
5. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle. Qu Q, Russell PL, Sharom FJ. Biochemistry; 2003 Feb 04; 42(4):1170-7. PubMed ID: 12549939 [Abstract] [Full Text] [Related]
6. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. Ramachandra M, Ambudkar SV, Chen D, Hrycyna CA, Dey S, Gottesman MM, Pastan I. Biochemistry; 1998 Apr 07; 37(14):5010-9. PubMed ID: 9538020 [Abstract] [Full Text] [Related]
7. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM. Biochemistry; 1998 Sep 29; 37(39):13660-73. PubMed ID: 9753453 [Abstract] [Full Text] [Related]
8. Fluorescence of native single-Trp mutants in the lactose permease from Escherichia coli: structural properties and evidence for a substrate-induced conformational change. Weitzman C, Consler TG, Kaback HR. Protein Sci; 1995 Nov 29; 4(11):2310-8. PubMed ID: 8563627 [Abstract] [Full Text] [Related]
12. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase. Rao US. Biochemistry; 1998 Oct 20; 37(42):14981-8. PubMed ID: 9778376 [Abstract] [Full Text] [Related]
15. The relationship between MRP1 activities and its NBD conformational changes. Huang Z, Huang Y. Sci China C Life Sci; 2004 Oct 20; 47(5):425-33. PubMed ID: 15623154 [Abstract] [Full Text] [Related]
18. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein. Maki N, Moitra K, Silver C, Ghosh P, Chattopadhyay A, Dey S. Biochemistry; 2006 Feb 28; 45(8):2739-51. PubMed ID: 16489767 [Abstract] [Full Text] [Related]
19. P glycoprotein and the mechanism of multidrug resistance. Váradi A, Szakács G, Bakos E, Sarkadi B. Novartis Found Symp; 2002 Feb 28; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782 [Abstract] [Full Text] [Related]
20. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway. Tombline G, Muharemagić A, White LB, Senior AE. Biochemistry; 2005 Sep 27; 44(38):12879-86. PubMed ID: 16171403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]